PD Dr. med. Andreas Neumayr, MD, DTM&H, MCTM
Profile
Andreas Neumayr heads the "Centre for Tropical and Travel Medicine" at the Swiss TPH. He completed his medical studies in Germany, worked at various university hospitals in the fields of internal medicine, anaesthesiology, intensive care, emergency medicine and infectious diseases in Germany and Switzerland and was trained in tropical medicine in Thailand, Peru and Laos. He habilitated in tropical and travel medicine at the University of Basel and is associate professor of tropical medicine at James Cook University in Townsville, Australia.
Professional qualifications:
- Specialisation in Internal Medicine, Germany
- Specialisation in Infectious Diseases, Switzerland
- Specialisation in Tropical and Travel Medicine, Switzerland
- Subspecialisation in Emergency Medicine, Germany
- Diploma in Tropical Medicine and Hygiene, Thailand
- Master in Clinical Tropical Medicine, Thailand
- International Diploma in Mountain Medicine (UIAA), Austria
- International Diploma in Expedition and Wilderness Medicine (UIAA), Austria
Latest Publications
All PublicationsHamelin B et al. Unbiased DNA pathogen detection in tissues: real-world experience with metagenomic sequencing in pathology. Lab Invest. 2026;106(1):104254. DOI: 10.1016/j.labinv.2025.104254
Richter J, Kling K, Hatz C, Neumayr A. Ultrasonographic findings in Schistosoma mekongi infection. A minireview. Parasitol Int. 2026;110:103138. DOI: 10.1016/j.parint.2025.103138
Richter J et al. Schistosoma japonicum infection: clinical significance of ultrasound findings. Trans R Soc Trop Med Hyg. 2026(in press). DOI: 10.1093/trstmh/traf134
Schumacher M et al. Amebic liver abscess with bronchopleural fistula. J Travel Med. 2026(in press). DOI: 10.1093/jtm/taag006
Adamiková L et al. Massnahmenplan: Empfehlungen zur Risikoreduktion von autochthonen Fällen von Dengue, Chikungunya und Zika. Bern: Bundesamt für Gesundheit, 2025
Carroll S.C, Castellanos M.E, Neumayr A, Henning L. What's the worst that could happen? The risk of illness, injury, and death related to international travel-the Australian experience. Travel Med Infect Dis. 2025;68:102933. DOI: 10.1016/j.tmaid.2025.102933
Ciminelli F, Buonfrate D, Mazzi C, Neumayr A, Camprubí-Ferrer D, Gobbi F. Effectiveness of dihydroartemisinin-piperaquine for treating Plasmodium falciparum malaria from sub-Saharan Africa: a retrospective study. Travel Med Infect Dis. 2025;68:102923. DOI: 10.1016/j.tmaid.2025.102923
Horton J.M, Neumayr A. Relapsing fever caused by Borrelia species. In: Blaser M. J,Cohen J. I,Holland S. M, eds. Mandell, Douglas, and Bennett's principles and practice of infectious diseases, 2905-2912. Philadelphia: Elsevier - Health Sciences Division, 2025
Kositz C, Gygax L, Schudel S, Kuenzli E, Neumayr A. Comparison of the epidemiological and clinical fingerprints of Human Granulocytotropic Anaplasmosis and Human Monocytotropic Ehrlichiosis in the United States. PLoS One. 2025;20(11):e0334957. DOI: 10.1371/journal.pone.0334957
Lindner A.K et al. Shortage of praziquantel in Europe: a clarion call for urgent action. New Microbes New Infect. 2025;66:101613. DOI: 10.1016/j.nmni.2025.101613